Use of antithrombotic agents during pregnancy

Chest

Volumn 114, Issue 5 SUPPL., 1998, Pages 524S-530S

  Ginsberg, Jeffrey S ^a   Hirsh, Jack ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; DANAPAROID; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; WARFARIN;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DISEASE; HEART VALVE PROSTHESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LACTATION; MATERNAL DISEASE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TERATOGENICITY; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0031729116     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5_Supplement.524S     Document Type: Conference Paper

References (2)

1. Sachs BP, Brown DA, Driscoll SG, et al. Maternal mortality in Massachusetts: trends and prevention. N Engl J Med 1987; 316:607-672
2. Bonnar J. Venous thromboembolism and pregnancy. Clin Obstet Gynecol 1981; 8:455-473